List of Excipients in API clindamycin phosphate and tretinoin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing clindamycin phosphate and tretinoin
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Almirall LLC | VELTIN | clindamycin phosphate and tretinoin | 16110-071 | ANHYDROUS CITRIC ACID | |
| Almirall LLC | VELTIN | clindamycin phosphate and tretinoin | 16110-071 | BUTYLATED HYDROXYTOLUENE | |
| Almirall LLC | VELTIN | clindamycin phosphate and tretinoin | 16110-071 | CARBOMER HOMOPOLYMER TYPE C | |
| Almirall LLC | VELTIN | clindamycin phosphate and tretinoin | 16110-071 | EDETATE DISODIUM | |
| Almirall LLC | VELTIN | clindamycin phosphate and tretinoin | 16110-071 | LAURETH-4 | |
| Almirall LLC | VELTIN | clindamycin phosphate and tretinoin | 16110-071 | METHYLPARABEN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing clindamycin phosphate and tretinoin
Detailed excipient profiles for clindamycin phosphate and tretinoin
Excipient focus: ANHYDROUS CITRIC ACID
clindamycin phosphate and tretinoin drug variants containing ANHYDROUS CITRIC ACID
clindamycin phosphate and tretinoin drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYTOLUENE
clindamycin phosphate and tretinoin drug variants containing BUTYLATED HYDROXYTOLUENE
clindamycin phosphate and tretinoin drug variants not containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOMER HOMOPOLYMER TYPE A
clindamycin phosphate and tretinoin drug variants containing CARBOMER HOMOPOLYMER TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Oceanside Pharmaceuticals | clindamycin phosphate and tretinoin | 68682-300 |
| Bausch Health US LLC | clindamycin phosphate and tretinoin | 99207-300 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate and tretinoin drug variants not containing CARBOMER HOMOPOLYMER TYPE A
Excipient focus: CARBOMER HOMOPOLYMER TYPE C
clindamycin phosphate and tretinoin drug variants containing CARBOMER HOMOPOLYMER TYPE C
| Company | Ingredient | NDC |
|---|---|---|
| Almirall LLC | clindamycin phosphate and tretinoin | 16110-071 |
| Prasco Laboratories | clindamycin phosphate and tretinoin | 66993-959 |
| Encube Ethicals Private Limited | clindamycin phosphate and tretinoin gel 1.2%/0.025% | 21922-050 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate and tretinoin drug variants not containing CARBOMER HOMOPOLYMER TYPE C
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | clindamycin phosphate and tretinoin | 0472-1790 |
| Oceanside Pharmaceuticals | clindamycin phosphate and tretinoin | 68682-300 |
| Bausch Health US LLC | clindamycin phosphate and tretinoin | 99207-300 |
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
clindamycin phosphate and tretinoin drug variants containing EDETATE DISODIUM
clindamycin phosphate and tretinoin drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
clindamycin phosphate and tretinoin drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | clindamycin phosphate and tretinoin | 0472-1790 |
| Oceanside Pharmaceuticals | clindamycin phosphate and tretinoin | 68682-300 |
| Bausch Health US LLC | clindamycin phosphate and tretinoin | 99207-300 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate and tretinoin drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Almirall LLC | clindamycin phosphate and tretinoin | 16110-071 |
| Prasco Laboratories | clindamycin phosphate and tretinoin | 66993-959 |
| Encube Ethicals Private Limited | clindamycin phosphate and tretinoin gel 1.2%/0.025% | 21922-050 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYETHYL CELLULOSE
clindamycin phosphate and tretinoin drug variants containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | clindamycin phosphate and tretinoin | 0472-1790 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate and tretinoin drug variants not containing HYDROXYETHYL CELLULOSE
Excipient focus: LAURETH-4
clindamycin phosphate and tretinoin drug variants containing LAURETH-4
| Company | Ingredient | NDC |
|---|---|---|
| Almirall LLC | clindamycin phosphate and tretinoin | 16110-071 |
| Encube Ethicals Private Limited | clindamycin phosphate and tretinoin gel 1.2%/0.025% | 21922-050 |
| Prasco Laboratories | clindamycin phosphate and tretinoin | 66993-959 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate and tretinoin drug variants not containing LAURETH-4
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | clindamycin phosphate and tretinoin | 0472-1790 |
| Oceanside Pharmaceuticals | clindamycin phosphate and tretinoin | 68682-300 |
| Bausch Health US LLC | clindamycin phosphate and tretinoin | 99207-300 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
clindamycin phosphate and tretinoin drug variants containing METHYLPARABEN
clindamycin phosphate and tretinoin drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
clindamycin phosphate and tretinoin drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | clindamycin phosphate and tretinoin | 0472-1790 |
| Oceanside Pharmaceuticals | clindamycin phosphate and tretinoin | 68682-300 |
| Bausch Health US LLC | clindamycin phosphate and tretinoin | 99207-300 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate and tretinoin drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Almirall LLC | clindamycin phosphate and tretinoin | 16110-071 |
| Prasco Laboratories | clindamycin phosphate and tretinoin | 66993-959 |
| Encube Ethicals Private Limited | clindamycin phosphate and tretinoin gel 1.2%/0.025% | 21922-050 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
clindamycin phosphate and tretinoin drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Almirall LLC | clindamycin phosphate and tretinoin | 16110-071 |
| Prasco Laboratories | clindamycin phosphate and tretinoin | 66993-959 |
| Encube Ethicals Private Limited | clindamycin phosphate and tretinoin gel 1.2%/0.025% | 21922-050 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate and tretinoin drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | clindamycin phosphate and tretinoin | 0472-1790 |
| Oceanside Pharmaceuticals | clindamycin phosphate and tretinoin | 68682-300 |
| Bausch Health US LLC | clindamycin phosphate and tretinoin | 99207-300 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
clindamycin phosphate and tretinoin drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | clindamycin phosphate and tretinoin | 0472-1790 |
| Oceanside Pharmaceuticals | clindamycin phosphate and tretinoin | 68682-300 |
| Bausch Health US LLC | clindamycin phosphate and tretinoin | 99207-300 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate and tretinoin drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Almirall LLC | clindamycin phosphate and tretinoin | 16110-071 |
| Prasco Laboratories | clindamycin phosphate and tretinoin | 66993-959 |
| Encube Ethicals Private Limited | clindamycin phosphate and tretinoin gel 1.2%/0.025% | 21922-050 |
| >Company | >Ingredient | >NDC |
Excipient focus: TROMETHAMINE
clindamycin phosphate and tretinoin drug variants containing TROMETHAMINE
clindamycin phosphate and tretinoin drug variants not containing TROMETHAMINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
clindamycin phosphate and tretinoin drug variants containing WATER
clindamycin phosphate and tretinoin drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: XANTHAN GUM
clindamycin phosphate and tretinoin drug variants containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | clindamycin phosphate and tretinoin | 0472-1790 |
| >Company | >Ingredient | >NDC |
clindamycin phosphate and tretinoin drug variants not containing XANTHAN GUM
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
